Connection
Yuya Hirasawa to Response Evaluation Criteria in Solid Tumors
This is a "connection" page, showing publications Yuya Hirasawa has written about Response Evaluation Criteria in Solid Tumors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.041 |
|
|
|
-
Matsumoto N, Kubota Y, Ishida H, Sekido M, Ohkuma R, Ishiguro T, Hirasawa Y, Ariizumi H, Tsunoda T, Ikusue T, Kobayashi K, Hisamatsu A, Toshima H, Shimada K, Fujita KI. Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients. Cancer Chemother Pharmacol. 2020 06; 85(6):1119-1128.
Score: 0.041